SEC Form D filing

Belhaven Biopharma Inc., 2025-10-15

An SEC Form D private-offering notice from Chapel Hill, NC, a $32,289,627 filer-stated offering target in Biotech. Filed 2025-10-15. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Belhaven Biopharma Inc. site↗ Verified via SEC Form D

Develops dry powder nasal drug delivery technology, including Nasdepi, a needle free nasal epinephrine alternative to injectable EpiPen style devices for anaphylaxis.

Filed 2025-10-15Filed to raise $32,289,627First money in 2025-08-04Raised so far $32,289,627HQ (as filed) Chapel Hill, NCSector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified belhavenbio.com↗Named in the filing 4 executives & directors
Open this row on the live feed →More new filings in North Carolina →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source